Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes

Among patients on peritoneal dialysis (PD), 50–80% will develop peritoneal fibrosis, and 0.5–4.4% will develop life-threatening encapsulating peritoneal sclerosis (EPS). Here, we investigated the role of extracellular vesicles (EVs) on the TGF-β- and PDGF-B-driven processes of peritoneal fibrosis. E...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Beáta Szebeni, Apor Veres-Székely, Domonkos Pap, Péter Bokrossy, Zoltán Varga, Anikó Gaál, Judith Mihály, Éva Pállinger, István M. Takács, Csenge Pajtók, Mária Bernáth, György S. Reusz, Attila J. Szabó, Ádám Vannay
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Subjects:	extracellular vesicles peritoneal dialysis fibrosis mesenchymal transition therapy
Online Access:	https://www.mdpi.com/2073-4409/13/7/605